[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Stem Cell Therapy Market Report 2017

November 2017 | 109 pages | ID: U0D278A52C2WEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Stem Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Stem Cell Therapy in these regions, from 2012 to 2022 (forecast).
United States Stem Cell Therapy market competition by top manufacturers/players, with Stem Cell Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Cellular Dynamics International
  • Osiris Therapeutics
  • Vcanbio
  • Gamida Cell
  • Golden Meditech
  • Celgene
  • Guanhao Biotech
  • Mesoblast
  • Vericel Corporation
  • Stemcell Technologes
  • Beike Biotechnology
  • Cytori Therapeutics
  • Bioheart
  • Pluristem Therapeutics
  • Fibrocell Science
  • Ocata Therapeutics
  • Athersys
  • Geron
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Autologous
  • Allogeneic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • CNS
  • CVS
  • GIT
  • Wounds and Injuries
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Stem Cell Therapy Market Report 2017

1 STEM CELL THERAPY OVERVIEW

1.1 Product Overview and Scope of Stem Cell Therapy
1.2 Classification of Stem Cell Therapy by Product Category
  1.2.1 United States Stem Cell Therapy Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Stem Cell Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Autologous
  1.2.4 Allogeneic
1.3 United States Stem Cell Therapy Market by Application/End Users
  1.3.1 United States Stem Cell Therapy Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 CNS
  1.3.3 CVS
  1.3.4 GIT
  1.3.5 Wounds and Injuries
  1.3.6 Others
1.4 United States Stem Cell Therapy Market by Region
  1.4.1 United States Stem Cell Therapy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Stem Cell Therapy Status and Prospect (2012-2022)
  1.4.3 Southwest Stem Cell Therapy Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Stem Cell Therapy Status and Prospect (2012-2022)
  1.4.5 New England Stem Cell Therapy Status and Prospect (2012-2022)
  1.4.6 The South Stem Cell Therapy Status and Prospect (2012-2022)
  1.4.7 The Midwest Stem Cell Therapy Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Stem Cell Therapy (2012-2022)
  1.5.1 United States Stem Cell Therapy Sales and Growth Rate (2012-2022)
  1.5.2 United States Stem Cell Therapy Revenue and Growth Rate (2012-2022)

2 UNITED STATES STEM CELL THERAPY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Stem Cell Therapy Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Stem Cell Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Stem Cell Therapy Average Price by Players/Suppliers (2012-2017)
2.4 United States Stem Cell Therapy Market Competitive Situation and Trends
  2.4.1 United States Stem Cell Therapy Market Concentration Rate
  2.4.2 United States Stem Cell Therapy Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Stem Cell Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES STEM CELL THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Stem Cell Therapy Sales and Market Share by Region (2012-2017)
3.2 United States Stem Cell Therapy Revenue and Market Share by Region (2012-2017)
3.3 United States Stem Cell Therapy Price by Region (2012-2017)

4 UNITED STATES STEM CELL THERAPY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Stem Cell Therapy Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Stem Cell Therapy Revenue and Market Share by Type (2012-2017)
4.3 United States Stem Cell Therapy Price by Type (2012-2017)
4.4 United States Stem Cell Therapy Sales Growth Rate by Type (2012-2017)

5 UNITED STATES STEM CELL THERAPY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Stem Cell Therapy Sales and Market Share by Application (2012-2017)
5.2 United States Stem Cell Therapy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES STEM CELL THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Cellular Dynamics International
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Stem Cell Therapy Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cellular Dynamics International Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Osiris Therapeutics
  6.2.2 Stem Cell Therapy Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Osiris Therapeutics Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Vcanbio
  6.3.2 Stem Cell Therapy Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Vcanbio Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gamida Cell
  6.4.2 Stem Cell Therapy Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gamida Cell Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Golden Meditech
  6.5.2 Stem Cell Therapy Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Golden Meditech Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celgene
  6.6.2 Stem Cell Therapy Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celgene Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Guanhao Biotech
  6.7.2 Stem Cell Therapy Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Guanhao Biotech Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mesoblast
  6.8.2 Stem Cell Therapy Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mesoblast Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Vericel Corporation
  6.9.2 Stem Cell Therapy Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Vericel Corporation Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Stemcell Technologes
  6.10.2 Stem Cell Therapy Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Stemcell Technologes Stem Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Beike Biotechnology
6.12 Cytori Therapeutics
6.13 Bioheart
6.14 Pluristem Therapeutics
6.15 Fibrocell Science
6.16 Ocata Therapeutics
6.17 Athersys
6.18 Geron

7 STEM CELL THERAPY MANUFACTURING COST ANALYSIS

7.1 Stem Cell Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Stem Cell Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Stem Cell Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Stem Cell Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES STEM CELL THERAPY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Stem Cell Therapy Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Stem Cell Therapy Sales Volume Forecast by Type (2017-2022)
11.3 United States Stem Cell Therapy Sales Volume Forecast by Application (2017-2022)
11.4 United States Stem Cell Therapy Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Stem Cell Therapy
Figure United States Stem Cell Therapy Market Size (K Units) by Type (2012-2022)
Figure United States Stem Cell Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Autologous Product Picture
Figure Allogeneic Product Picture
Figure United States Stem Cell Therapy Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Stem Cell Therapy by Application in 2016
Figure CNS Examples
Table Key Downstream Customer in CNS
Figure CVS Examples
Table Key Downstream Customer in CVS
Figure GIT Examples
Table Key Downstream Customer in GIT
Figure Wounds and Injuries Examples
Table Key Downstream Customer in Wounds and Injuries
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Stem Cell Therapy Market Size (Million USD) by Region (2012-2022)
Figure The West Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Stem Cell Therapy Sales (K Units) and Growth Rate (2012-2022)
Figure United States Stem Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Stem Cell Therapy Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Stem Cell Therapy Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Stem Cell Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Stem Cell Therapy Sales Share by Players/Suppliers
Figure 2017 United States Stem Cell Therapy Sales Share by Players/Suppliers
Figure United States Stem Cell Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Stem Cell Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Stem Cell Therapy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Stem Cell Therapy Revenue Share by Players/Suppliers
Figure 2017 United States Stem Cell Therapy Revenue Share by Players/Suppliers
Table United States Market Stem Cell Therapy Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Stem Cell Therapy Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Stem Cell Therapy Market Share of Top 3 Players/Suppliers
Figure United States Stem Cell Therapy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Stem Cell Therapy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Stem Cell Therapy Product Category
Table United States Stem Cell Therapy Sales (K Units) by Region (2012-2017)
Table United States Stem Cell Therapy Sales Share by Region (2012-2017)
Figure United States Stem Cell Therapy Sales Share by Region (2012-2017)
Figure United States Stem Cell Therapy Sales Market Share by Region in 2016
Table United States Stem Cell Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Stem Cell Therapy Revenue Share by Region (2012-2017)
Figure United States Stem Cell Therapy Revenue Market Share by Region (2012-2017)
Figure United States Stem Cell Therapy Revenue Market Share by Region in 2016
Table United States Stem Cell Therapy Price (USD/Unit) by Region (2012-2017)
Table United States Stem Cell Therapy Sales (K Units) by Type (2012-2017)
Table United States Stem Cell Therapy Sales Share by Type (2012-2017)
Figure United States Stem Cell Therapy Sales Share by Type (2012-2017)
Figure United States Stem Cell Therapy Sales Market Share by Type in 2016
Table United States Stem Cell Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Stem Cell Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Stem Cell Therapy by Type (2012-2017)
Figure Revenue Market Share of Stem Cell Therapy by Type in 2016
Table United States Stem Cell Therapy Price (USD/Unit) by Types (2012-2017)
Figure United States Stem Cell Therapy Sales Growth Rate by Type (2012-2017)
Table United States Stem Cell Therapy Sales (K Units) by Application (2012-2017)
Table United States Stem Cell Therapy Sales Market Share by Application (2012-2017)
Figure United States Stem Cell Therapy Sales Market Share by Application (2012-2017)
Figure United States Stem Cell Therapy Sales Market Share by Application in 2016
Table United States Stem Cell Therapy Sales Growth Rate by Application (2012-2017)
Figure United States Stem Cell Therapy Sales Growth Rate by Application (2012-2017)
Table Cellular Dynamics International Basic Information List
Table Cellular Dynamics International Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cellular Dynamics International Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Cellular Dynamics International Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Cellular Dynamics International Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Osiris Therapeutics Basic Information List
Table Osiris Therapeutics Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Osiris Therapeutics Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Osiris Therapeutics Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Osiris Therapeutics Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Vcanbio Basic Information List
Table Vcanbio Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vcanbio Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Vcanbio Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Vcanbio Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Gamida Cell Basic Information List
Table Gamida Cell Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gamida Cell Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Gamida Cell Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Gamida Cell Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Golden Meditech Basic Information List
Table Golden Meditech Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Golden Meditech Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Golden Meditech Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Golden Meditech Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Celgene Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Celgene Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Celgene Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Guanhao Biotech Basic Information List
Table Guanhao Biotech Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Guanhao Biotech Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Guanhao Biotech Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Guanhao Biotech Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Mesoblast Basic Information List
Table Mesoblast Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mesoblast Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Mesoblast Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Mesoblast Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Vericel Corporation Basic Information List
Table Vericel Corporation Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vericel Corporation Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Vericel Corporation Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Vericel Corporation Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Stemcell Technologes Basic Information List
Table Stemcell Technologes Stem Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Stemcell Technologes Stem Cell Therapy Sales Growth Rate (2012-2017)
Figure Stemcell Technologes Stem Cell Therapy Sales Market Share in United States (2012-2017)
Figure Stemcell Technologes Stem Cell Therapy Revenue Market Share in United States (2012-2017)
Table Beike Biotechnology Basic Information List
Table Cytori Therapeutics Basic Information List
Table Bioheart Basic Information List
Table Pluristem Therapeutics Basic Information List
Table Fibrocell Science Basic Information List
Table Ocata Therapeutics Basic Information List
Table Athersys Basic Information List
Table Geron Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Stem Cell Therapy
Figure Manufacturing Process Analysis of Stem Cell Therapy
Figure Stem Cell Therapy Industrial Chain Analysis
Table Raw Materials Sources of Stem Cell Therapy Major Players/Suppliers in 2016
Table Major Buyers of Stem Cell Therapy
Table Distributors/Traders List
Figure United States Stem Cell Therapy Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Stem Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Stem Cell Therapy Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Stem Cell Therapy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Stem Cell Therapy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Stem Cell Therapy Sales Volume (K Units) Forecast by Type in 2022
Table United States Stem Cell Therapy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Stem Cell Therapy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Stem Cell Therapy Sales Volume (K Units) Forecast by Application in 2022
Table United States Stem Cell Therapy Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Stem Cell Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Stem Cell Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Stem Cell Therapy Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories